Allan Oberman

Allan Grant Oberman is the founder of RNA Disease Diagnostics, Inc., founded in 2020, serving as Chairman.
Current jobs include Director at Apotex, Inc. starting in 2023, Director at Planet Shrimp, Inc., Director at Jay Pharma, Inc., and Non-Executive Director at Apotex Health Corp.
starting in 2023.
Former jobs include Chief Executive Officer at Novopharm Ltd., President & Chief Executive Officer at Teva Pharmaceuticals USA, Inc. from 2012 to 2014, Chief Executive Officer & Director at Sagent Pharmaceuticals, Inc. from 2015 to 2016, President & Chief Executive Officer at Teva Canada Ltd. from 2000 to 2008, Chief Executive Officer & Executive Director at Advanz Pharma Corp.
Ltd. from 2016 to 2018, President & Chief Executive Officer at Teva Generics, Vice Chairman at the Association for Accessible Medicines, Chairman at The Canadian Generic Pharmaceutical Association, Chairman at Jay Pharma, Inc. (Canada), Independent Non-Executive Director at Dr. Reddy's Laboratories Ltd. from 2019 to 2023, Director at The Baycrest Centre Foundation, Director at Food & Consumer Products of Canada, Director at Concordia Pharmaceuticals (US), Inc., Director at Electronic Commerce Council of Canada, President-EMIA at Teva Pharmaceutical Industries Ltd. from 2010 to 2012, Member-Associate Board at The Canadian Association of Chain Drug Stores, President at Best Foods Canada, Inc. from 1996 to 2000, and Chief Operating Officer at Teva International Group from 2008 to 2010.
Education includes undergraduate studies at the University of Western Ontario and an MBA from The Schulich School of Business.